je.st
news
Allergan tells shareholders to reject Valeant deal
2014-06-23 16:54:08| Biotech - Topix.net
Allergan, the maker of Botox, said Monday that Valeant Pharmaceuticals' hostile takeover bid for the company is "grossly inadequate" and that shareholders should reject it.
Tags: deal
tells
shareholders
reject
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||